Log in to save to my catalogue

Drug Toxicity, HIV Progression, or Comorbidity of Aging: Does Tipranavir Use Increase the Risk of In...

Drug Toxicity, HIV Progression, or Comorbidity of Aging: Does Tipranavir Use Increase the Risk of In...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_21407020

Drug Toxicity, HIV Progression, or Comorbidity of Aging: Does Tipranavir Use Increase the Risk of Intracranial Hemorrhage?

About this item

Full title

Drug Toxicity, HIV Progression, or Comorbidity of Aging: Does Tipranavir Use Increase the Risk of Intracranial Hemorrhage?

Publisher

Chicago, IL: The University of Chicago Press

Journal title

Clinical infectious diseases, 2008-11, Vol.47 (9), p.1226-1230

Language

English

Formats

Publication information

Publisher

Chicago, IL: The University of Chicago Press

More information

Scope and Contents

Contents

The US Food and Drug Administration has issued a warning that tipranavir may be associated with increased risk of intracranial hemorrhage. We studied 2 large cohorts to estimate the background rate of intracranial hemorrhage and compared it with rates reported among persons who had been exposed to tipranavir.

Alternative Titles

Full title

Drug Toxicity, HIV Progression, or Comorbidity of Aging: Does Tipranavir Use Increase the Risk of Intracranial Hemorrhage?

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_21407020

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_21407020

Other Identifiers

ISSN

1058-4838

E-ISSN

1537-6591

DOI

10.1086/592302

How to access this item